Amgad El Mekabaty

Amgad El Mekabaty

Auto-generated profile, based on publicly available information

Amgad El Mekabaty

Institut für Medizinische Radiologie (IMR) Bürgerspital Solothurn, Solothurn, Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2016 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
AMAmgad El Mekabaty
Amgad El Mekabaty
NONancy A Obuchowski
Nancy A Obuchowski
MLMark G Luciano
Mark G Luciano
SJSeby John
Seby John
CCCharlotte Y Chung
Charlotte Y Chung
FHFerdinand K Hui
Ferdinand K Hui
Background Venous sinus stenting for dural sinus stenoses is an emerging alternative to cerebrospinal fluid diversion in cases of medically refractory idiopathic intracranial hypertension. Juxta-stent ‘re-stenoses’ have been reported and managed alternatively with ventricular shunting or stent revision. Identification of factors that might predispose patients to recurrent narrowing may help to select or exclude patients with idiopathic intracranial hypertension for venous sinus stenting. Methods We retrospectively reviewed a prospectively maintained database spanning December 2011 to May 2015 of all patients with idiopathic intracranial hypertension who were screened for possible venous sinus stenting, including only patients who received a stent, noting symptomatic improvements, changes in opening lumbar puncture pressure, demographic characteristics, and any subsequent intervention after stent placement. Fisher's exact test and logistic regression were used to test each of seven potential predictors for retreatment. Results There were eight revisions in 31 patients (25.8%). Among Caucasians, 8.0% required a revision compared with 100% of African-Americans (p<0.001). The c-index for race was 0.857. Body mass index (BMI) was also a significant predictor of revision (p=0.031): among class III obese patients the revision rate was 46.2% compared with 16.7% among class I and II obese patients and 0% among overweight to normal weight patients. Conclusions BMI was a significant predictor of revision, suggesting that higher BMI may have a higher risk of revision. The small number of African-Americans in the study makes interpretation of the practical significance of the revision rate in these patients uncertain. None of the other studied factors was statistically significant.

10 June 2020 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
AMAmgad El Mekabaty
Amgad El Mekabaty
MPMonica Smith Pearl
Monica Smith Pearl
AMAbhay Moghekar
Abhay Moghekar
PGPhilippe Gailloud
Philippe Gailloud
Background Transverse sinus (TS) stenting is a valid treatment alternative for patients with intracranial hypertension caused by underlying bilateral TS stenoses. Its mid-term patency has, however, not been well documented. Objective To assess the 6-month patency of TS stenting using subtracted CT venography (CTV). Methods A retrospective analysis of a prospectively collected database of patients undergoing TS stenting was performed. The cohort was a single-center, single-operator series of 125 consecutive patients treated between 2008 and 2018. Mid-term follow-up 320-row detector CTV was available for review in 104 patients. Results Follow-up CTV was obtained on average 6 months after stenting. Stents in all patients (100%) were patent. Subtracted reconstructions showed no intraluminal thrombus or neointimal hyperplasia. Native reconstructions confirmed the structural integrity of the stents. De novo stenosis proximal to the stent was noted in 10 cases (10%). A total of 10 patients (10%) received additional treatment due to recurrent symptoms. In univariate analysis, both high body mass index and stent size (>6 mm) were associated with development of de novo stenoses: OR 1.12 (95% CI 1.01 to 1.25, p=0.037) and OR 5.63 (95% CI 1.16 to 27.22, p=0.032), respectively. In multivariate analysis, only stent size (>6 mm) remained significant: OR 7.19 (95% CI 1.03 to 50.01, p=0.046). Conclusion TS stenting is an effective treatment for intracranial hypertension secondary to dural sinus stenosis in an appropriately selected patient population. A 320-row dynamic CTV is a high-quality non-invasive imaging method that can assess both the physical integrity of the stent and its patency. At mid-term follow-up, all imaged stents were patent. The occurrence of de novo stenoses proximal to the stent (10%) correlated with stent size (>6 mm).

2 May 2017 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
FHFerdinand K Hui
Ferdinand K Hui
AMAmgad El Mekabaty
Amgad El Mekabaty
JSJacky Schultz
Jacky Schultz
KHKelvin Hong
Kelvin Hong
KHKaren Horton
Karen Horton
ZNZurab Nadareishvili
Zurab Nadareishvili
Background and purpose It is increasingly recognized that time is one of the key determinants in acute stroke outcome when interventional stroke therapy is applied. With increasing device efficacy and understanding of imaging triage options, reducing pre-treatment time loss may be a critical component of improving interventional stroke outcomes for the population at large. Time sensitive procedures such as organ harvest have transported physicians to the patient site to improve time to procedure. Applying this same principle to interventional stroke management may be a valid paradigm. Methods Previous logistical deliberation with hospital and Medevac companies was carried out to provide the rationale and funding for helicopter transfer of a neurointerventionalist to an in-network hospital with an on-site angiographic suite. An appropriate patient with large vessel occlusion and an NIH Stroke Scale score >8 was identified. MRI was performed, then the Medevac transport system was activated and the intervention was carried out. Times were collected during the case and assessed for time efficiency. Results The proof of concept case was identified and Medevac was consulted at 12:13 after verifying that no in-house emergencies would prevent physician departure. Weather clearance was obtained and stroke intervention confirmed as a go at 12:24. Groin puncture occurred at 13:07 and the intervention was completed at 13:41. The total time from decision-to-treat to groin puncture was 43 min and groin closure was completed at 77 min from decision-to-treat. Conclusions This proof of concept case is presented for logistical, financial and use-case analysis. As it is a first case, times can likely be improved. We assert that this model may be another option in the spoke-and-hub design of stroke systems of care.

1 May 2020 in Radiology
Verified
Journal Article
Closed access
EOEmanuele Orrù
Emanuele Orrù
AMAmgad El Mekabaty
Amgad El Mekabaty
DMDiego San Millan
Diego San Millan
MPMonica S. Pearl
Monica S. Pearl
PGPhilippe Gailloud
Philippe Gailloud
Removal of antiscatter grids during spinal angiography reduces radiation exposure to patients and operators while maintaining acceptable diagnostic image quality; this dose-reduction technique may ... Background Spinal digital subtraction angiography (DSA) exposes patients and operators to substantial amounts of radiation. Antiscatter grid (ASG) removal is used to decrease radiation exposure but...

1 June 2020 in World Neurosurgery
Verified
Journal Article
Closed access
AMAmgad El Mekabaty
Amgad El Mekabaty
AGAllan Gottschalk
Allan Gottschalk
AMAbhay Moghekar
Abhay Moghekar
EOEmmanuel Obusez
Emmanuel Obusez
MKMajid Khan
Majid Khan
FHFerdinand K. Hui
Ferdinand K. Hui

1 May 2019 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
AMAmgad El Mekabaty
Amgad El Mekabaty
MPMonica S. Pearl
Monica S. Pearl
BMBommy Mershon
Bommy Mershon
IBIvor Berkowitz
Ivor Berkowitz
PGPhilippe Gailloud
Philippe Gailloud
THThierry A.G.M. Huisman
Thierry A.G.M. Huisman